International Journal of Health Sciences and Research ISSN:

Similar documents
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment

Education. Panel. Triglycerides & HDL-C

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Cardiovascular Disease Risk Factors

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

How To Treat Dyslipidemia

Guidelines for the management of hypertension in patients with diabetes mellitus

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

Coronary Heart Disease (CHD) Brief

Evaluation of Non-HDL-Cholesterol/HDL-cholesterol ratio as a predictor of coronary artery disease

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Diabetes and Heart Disease

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing

What is a Heart Attack? 1,2,3

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.

Prognostic impact of uric acid in patients with stable coronary artery disease

High Blood Cholesterol

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Sinclair Community College, Division of Allied Health Technologies

NCD for Lipids Testing

LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

Cholesterol and Triglycerides What You Should Know

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke

Pantesin Effective support for heart healthy cholesterol levels*

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires

WHO STEPwise approach to chronic disease risk factor surveillance (STEPS)

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Health Maintenance: Controlling Cholesterol

Triglycerides: Frequently Asked Questions

Darlene Langhoff St. Thomas More High Ron Gerrits MSOE

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075

Listen to your heart: Good Cardiovascular Health for Life

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

National Lipid Association 2014 Scientific Sessions, Orlando, FL

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Margarines and Heart Disease. Do they protect?

Diabetes and Your Kidneys

THE THIRD REPORT OF THE EXpert

Insulin Resistance and PCOS: A not uncommon reproductive disorder

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement

CHOLESTEROL 101: WHAT YOU NEED TO KNOW TO KEEP YOUR HEART HEALTHY. By: Camille Quiles, PharmD., RPh.

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%

25-hydroxyvitamin D: from bone and mineral to general health marker

The International Agenda for Stroke

Proposed FDA Rule To Ban Partially Hydrogenated (PHO) Oils. Johari Minal

Primary Care Physicians' Agreement With NCEP-ATP II Guidelines in Hylipidemia Management

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

ECONOMIC COSTS OF PHYSICAL INACTIVITY

An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Facts About Peripheral Arterial Disease (P.A.D.)

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

METABOLIC SYNDROME. Rebecca Rovay-Hazelton, Licensed Nutritionist

Multiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden

Overview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU

HEDIS CY2012 New Measures

EPA/DHA Omega-3 Fatty Acids in the Primary and Secondary Prevention of Cardiovascular Disease and the Modification of Risk Factors

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

MY TYPE 2 DIABETES NUMBERS

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Mild Cognitive Impairment

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME

Understanding diabetes Do the recent trials help?

RESPONSE OF CHOLESTEROL IN THE PRESENCE OF ALANINE AND OTHER BLOOD CONSTITUENTS

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

African Americans & Cardiovascular Diseases

To study serum uric acid, serum lipid profile in type-2 diabetes mellitus.

Stress is linked to exaggerated cardiovascular reactivity. 1) Stress 2) Hostility 3) Social Support. Evidence of association between these

Improving cardiometabolic health in Major Mental Illness

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cholesterol made simple!

Prescription Cholesterol-lowering Medication Use in Adults Aged 40 and Over: United States,

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

Version Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Freiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal.

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

Cardiovascular Disease and the Endothelium

Cardiac Rehabilitation

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Heart Healthy Living

Antiretroviral treatment is Associated with increased Arterial Stiffness in Sub- Saharan African HIV-1 Infected Patients: A cross- Sectional Study

ACUTE CORONARY SYNDROME By Dr wasfi al abadi md jbc, dr walid sawalha mbbs mrcp jbc

Acquired Heart Disease: Prevention and Treatment

Using Family History to Improve Your Health Web Quest Abstract

Transcription:

International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Possible Relationship between LDL/HDL Cholesterol Ratio and HDL as A Surrogate Marker in Acute Myocardial Infarction Sheetal S Ghodke 1, Ramchandra K Padalkar 1, Sonali S Bhagat 1*, Rahul A Ghone 1, Sangita M Patil 1 1 Department of Biochemistry, PDVVPF s Medical College, Ahmednagar, (MS), India * Correspondence Email: bhtsonal@gmail.com Received: 24/08//2012 Revised: 18/09/2012 Accepted: 22/09/2012 ABSTRACT Acute Myocardial Infarction (MI) is one of the important reasons for death and unhealthiness in the world. In patients with acute Myocardial Infarction, cholesterol levels are no longer valid after 24 hrs from presentation, because acute Myocardial Infarction causes a rapid decline in serum levels of Total cholesterol and HDL cholesterol. The objectives of this study were to evaluate the Fasting levels of serum total cholesterol, high density Lipoprotein (HDL) cholesterol, low density Lipoprotein (LDL) cholesterol, very low density Lipoprotein (VLDL) cholesterol, Triglyceride (TG), HDL cholesterol / LDL cholesterol ratio. The diagnosis is based on the ECG and enzyme profile. Increased total LDH level was taken as criteria for selection of patients. Total 80 cases were studied in the age group 30 to 80 years and status was compared with 80 age and sex matched healthy controls in the same age group. A significant elevations were found in the levels of total cholesterol, LDL cholesterol and LDL cholesterol / HDL cholesterol ratio (p<0.001). these results indicates that the high levels of total cholesterol and LDL cholesterol / HDL cholesterol ratio are associated with risk of Myocardial Infarction in adult and detection of this ratio still could be useful for cholesterol risk assessment in patients with Acute Myocardial Infarction. Key Words- Acute Myocardial Infarction (AMI), Lipid Profile, LDL cholesterol / HDL cholesterol ratio, Coronary Artery Disease. INTRODUCTION Acute Myocardial Infarction (AMI) is one of the most common diseases among the developing countries. MI is defined as prolonged chest pain and is diagnosed as acute myocardial infarction on clinical examination, electrocardiographic changes and laboratory basis (1). The mortality rate of MI is approximately 30% and for every 1 in 25 patients who survive the initial International Journal of Health Sciences & Research (www.ijhsr.org) 83

hospitalization, dies in the first year after AMI. Indians are four time more prone to AMI as compared to the people of other countries due to a combination of the genetic and lifestyle factors that promote metabolic dysfunction. The risk of cardiovascular disease is predicted by various factors such as age, sex, smoking, hypertension and dyslipidemia (1). Elevated serum triglyceride, total cholesterol and LDL cholesterol are well established risk factor, for cardiovascular disease (2-7). A low serum HDL cholesterol level is therefore, thought to be an independent cardiovascular risk factor that leads to the development of atherosclerosis and related cardiovascular events (8). Many large scale studies have shown a high correlation between total plasma cholesterol and LDL levels and the severity of atherosclerosis as judged by the mortality rate from ischemic heart disease (9). This is why; it was considered a consequence of hyperlipidemia, especially hypercholesterolemia. It is well established that a western lifestyle, a high fat, high calorie diet, physical inactivity and tobacco smoking plays a major role in the causes and risk of MI. The biochemical or physiological consequences of this lifestyle include elevated blood pressure, elevated plasma cholesterol, low plasma high density lipoprotein (HDL) cholesterol, elevated plasma TG, diabetes, obesity and thrombogenic factors (10). Several epidemiologic studies have shown that the ratio of total cholesterol to HDL cholesterol and LDL cholesterol to HDL cholesterol also can be used as predictors of MI (11). The present study was conducted to evaluate the association of lipid profile and LDL/HDL ratio in the patients with first Myocardial Infarction. MATERIAL AND METHODS The present research was carried out in the Department of Biochemistry, B. J. Medical College, Pune in collaboration with Sassoon General Hospital, Pune and Department of Biochemistry PDVVPF s Medical College, Ahmednagar, Maharashtra. The Institutional Ethical Committee clearance was obtained and utmost care was taken during experimental procedure according to the Declaration of Helsinki 1975. The study had been performed on total 160 cases, which included 80 age and sex matched (48 males and 33 females) healthy controls and 80 (64 males and 16 females) myocardial infarction patients which were previously diagnosed by ECG and enzyme profile. Increased total LDH level was taken as criteria for selection of patients. All patients were under the strict supervision of medical professionals during this period. All the patients having history of any heart disease, hypertension, thyroid dysfunction, diabetes mellitus were excluded from the study. Screening with complete blood count, ESR, fasting blood glucose was performed and if found abnormal, were excluded from the study. After obtaining a written consent from all the participants, total 5ml blood was withdrawn aseptically from the antecubital vein from each subject in plain bulb after 12 hrs overnight night fast. The samples were centrifuged at 3000 rpm for 10 min to separate. The separated serum was collected in polythene tube with cork and stored at - 20 0 C. The serum with no sign of hemolysis was used for analysis of all the parameters. Fasting levels of serum total cholesterol, high density Lipoprotein (HDL) cholesterol, low density Lipoprotein (LDL) cholesterol, very low density Lipoprotein (VLDL) cholesterol, Triglyceride (TG), HDL cholesterol / LDL cholesterol ratio were measured by enzymatic methods using International Journal of Health Sciences & Research (www.ijhsr.org) 84

Kits form Erba chem. Limited on spectrophotometer techniques (Model Chemiline CL/310 UV/VIS) in the Biochemistry lab. The statistical analysis was carried out by using the SPSS (Statistical Package for Social Sciences) software. The Student t test was applied for the statistical analysis and the results were expressed in mean ± SD, p values (p <0.001) were considered as highly significant. RESULT The clinical characteristics of acute myocardial infarction patients and control subjects have been shown in table 1. Table 1: Statistical comparison was done between Acute MI patients and control group. Sr no. Parameters Acute MI patients (n=80) Control group (n=80) 1 Total cholesterol (mg/dl) 200.86 ± 44.24* 181.63 ± 11.97 2 LDL cholesterol (mg/dl) 151.76 ± 35.4* 121.13 ± 21.3 3 VLDL cholesterol (mg/dl) 32.64 ± 4.87* 23.65 ± 5.13 4 HDL cholesterol (mg/dl) 39.05 ± 5.08* 57.71± 7.34 5 Triglyceride (TG) (mg/dl) 176.98 ± 19.54* 121.63 ± 32.05 6 HDL cholesterol / LDL cholesterol ratio 3.86 ± 1.27* 1.59 ± 0.60 Values are expressed in mean with standard deviation (mean ± SD). *p<0.001- considered as highly significant. n= number of subjects. Table-1 indicates significantly elevated (p<0.001) levels of serum total cholesterol, low density Lipoprotien (LDL) cholesterol, very low density Lipoprotien (VLDL) cholesterol, Triglyceride (TG), HDL cholesterol / LDL cholesterol ratio as compared to control subject. Also the level of serum high density Lipoprotien (HDL) cholesterol was found significantly lower when compared to control subject. DISCUSSION Coronary artery diseases are the most important factors of death. There is an increasing prevalence of these diseases in developing countries (12). Serum cholesterol alone is poor indicator of CHD risk which is much increased when other risk factors are present. Because well established risk factor such as smoking, serum cholesterol, hypertension and diabetes acts together to produce a heightened level of risk, the importance of rigorous sustained intervention in individuals with multiple risk factors for CHD cannot be overstated. Clinical epidemiological data also point to considering the athrogenic profile of the individual by using serum total cholesterol, HDL cholesterol and TG in the initial patient s assessment (10). Many studies in the past few decades have shoes that acute MI results in significant increase in the serum levels of total cholesterol, LDL cholesterol and TG (11). In our study we have found that there is significantly increase in total cholesterol level and it ha supported by the Salahuddin et al and Ahmed Shirakan et al. Elevated serum cholesterol level has depends on consumption of fat and genetic basis (9, 12, 13). In our present study serum triglyceride levels significantly increase in International Journal of Health Sciences & Research (www.ijhsr.org) 85

AMI patients when compared with control subjects. There is different mechanism about elevation of TG after MI. it is reported that elevated TG levels may depends on genetic and nutritional basis. TG change level may because inherited abnormality of very low density lipoprotein. It may happen because of increased flowing of fatty acids and impaired elimination of VLDL from the plasma. Our results are supported by other researchers (9, 12, 14, 15). The VLDL cholesterol and LDL cholesterol has found to be elevated significantly when compared with controls. LDL carries the most of the cholesterol in the plasma and increasing of LDL depend on increasing of total cholesterol (9, 10, 12). Low HDL cholesterol is shown to be associated with higher prevalence and incidence of coronary artery diseases (9, 16). Reduction in HDL cholesterol concentration in our finding is agreement with other studies. According to Robert H Glew et al, the dairy products such as milk, butter, and cheese are excellent sources of trans fatty acids that decrease HDL cholesterol, and increase the risk of cardiovascular disease (8). Several studies have supported that the ratio of LDL cholesterol/ HDL cholesterol shows the atherosclerotic injuries of the wall of the vessels (12). We found the significant increase in the ratio of LDL:HDL cholesterol level after acute MI. Our study has been supported by latest studies (12, 17, 18). LDL cholesterol level may be increased as a result of reducing in refining or excessive production of LDL cholesterol. LDL cell surface receptors may changes as a result of coronary heart disease, thus uptake of LDL cholesterol is decreased. On the other hand, increase in LDL possibly as a result of excessive production of VLDL or decrease of VLDL remnants. The result of our study shows significant elevations in total cholesterol, LDL cholesterol, VLDL cholesterol, TG and LDL cholesterol/ HDL cholesterol ratio after acute MI. CONCLUSION The core of our research lies in a fact that, there is a significant association of lipid profile with acute myocardial infarction. Changing of dietary and social activity habits of people in this area can help to prevent future atherogenic damaging in AMI patients. Reducing serum HDL cholesterol level in our study may be one of the effective reasonable lipid disorders in acute myocardial infarction. ACKNOWLEDGEMENT The author deeply acknowledges Dr. Phatke cardiologist and Prof. Dept of Medicine, PDVVPFs Medical College Ahmednagar [M.S.] India for allowing me to collect the blood sample from Hospital. REFERENCES 1. Sathisa TG, manjunatha Goud BK, Avinash SS et al. Microalbunuria in Non Diabetic, Non Hypertensive Myocardial Infarction in South Indian Patients With Relation To Lipid Profile and Cardiac Markers. J of clinical and Diagnostic Research 2011;5(6):1158-1160. 2. American Diabetes Association: Clinical recommendations 2001: Diabetic nephropathy. Diabetes Care 2001;24(1):69-72. 3. Kritchevsky D, Moyer AW, Tesar WC et al. Cholesterol vehicle in experimental atherosclerosis. II. Influence of unsaturation. Am J Physiol 1956;185:279-280. 4. Schaefer EJ. Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 2002;75:191-212. 5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. International Journal of Health Sciences & Research (www.ijhsr.org) 86

Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97. 6. World Health Organization. Diet, nutrition, and the prevention of chronic diseases; report of a WHO Study Group on Diet, Nutrition and Prevention of Noncommunicable Diseases. Geneva: World Health Organization, 1990:54-8. (Technical report series no. 797). 7. Yu-Poth S, Zhao G, Etherton T et al. Effects of National Cholesterol Educations Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999;69:632-646. 8. Robert H. Glew, Henry Okolie, Michael Crossey et al. Serum Lipid Profiles and Homocysteine Levels in Adults with Stroke or Myocardial Infarction in the Town of Gombe in Northern Nigeria. J Health Popul Nutr 2004 Dec;22(4):341-347. 9. Bibi Kulsoom, Nazrul Hasnain. Association of serum C reactive protein and LDL:HDL with Myocardial Infarction. J Pak Med Asso 2006;56(7);318-322 10. Isles CG, Paterson JR. Identifying patients at risk for coronary heart disease: implications from trials of lipid lowering drug therapy. Q J med 2000;93:567-574. 11. Norrapol Wattanasuwan, Ijaz A. Khan, Ramesh M. Gowda et al. Effect of Acute Myocardial Infarction on Cholesterol Ratios. Chest 2001;120:1196-1199. 12. Ahmad Shirafkan, Abdoljalal Marjani, Farhad Zaker. Serum lipid profiles in acute myocardial infarction patients in Gorgan. Biomedical Research 2012: 23(1): 119-124. 13. Salahuddin, Karira KA, Shah SMA, et al. Serum homocysteine in patients with acute myocardial infarction.pakistan J Cardiol. 2000; 11: 93-99. 14. Buring JE, O Cnnor GT, Goldhaber SZ et al. Decreased LDH2 and LDH3 cholesterol, Apo A-I, Apo A- II and increased risk of myocardial infarction. Circulation 1992;85:22-29. 15. A Hamsten, G Walldius, A Szamosi, et al. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation. 1986;73:1097-1110. 16. Toth PP. High density lipoprotein and cardiovascular risk. Circulation 2004;109;1809-1812. 17. Vetter NJ, Adams W, Strange RC, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 284-289. 18. Sandkamp M, Funke H and Schulte H : Lipoprotein (a) is an independent risk factor for myocardial infarction. Clin Chem 1990; 36: 20-23. ********************** International Journal of Health Sciences & Research (www.ijhsr.org) 87